More on TARS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+54.2% Growth)
- Ratings (9.1 Score)

Upcoming Events

- Earnings (8/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Tarsus Pharmaceuticals (NQ:TARS)
Delayed: 60.12 +1.46 (2.49%)
Prev. Close $58.66  
Open$58.74 
52 Wk High$ 
52 Wk Low$ 
Day High$61.21 
Day Low$58.74 
P/E N/A  
EPS$ 
Volume725,405 

Friends, Peers and Foes (?): ELAN, CTRX, DVAX, GBT, H1ZN34 (more...)

Jul 21, 2026 06:45 AM Tarsus Pharmaceuticals (TARS) PT Lowered to $89 at Guggenheim
Jul 13, 2026 04:14 PM Tarsus Pharmaceuticals CCO to depart for medical device CEO role
Jul 13, 2026 04:12 PM Form 8-K Tarsus Pharmaceuticals, For: Jul 13
Jul 13, 2026 04:05 PM Tarsus Pharmaceuticals Announces Executive Leadership Transition as Company Advances Next Phase of Growth
Jul 9, 2026 06:48 AM H.C. Wainwright Reiterates Buy Rating on Tarsus Pharmaceuticals (TARS)
Jul 8, 2026 04:14 PM Form 8-K Tarsus Pharmaceuticals, For: Jul 06
Jul 8, 2026 04:05 PM Tarsus acquires iRenix Medical for up to $565M in eye care deal
Jul 8, 2026 04:05 PM Tarsus Advances Eye Care Leadership Strategy with Acquisition of iRenix Medical and Late-Stage Asset IRX-101
Jul 1, 2026 01:29 PM Tarsus shares fall after short seller report
Jul 1, 2026 01:04 PM Culper Research short Tarsus Pharmaceuticals
View All Articles

Entities mentioned with TARS

View All Entities